NYSE American - Nasdaq Real Time Price USD

AIM ImmunoTech Inc. (AIM)

0.4850 +0.0081 (+1.70%)
As of 1:13 PM EDT. Market Open.
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2022
12/31/2021
12/31/2020
Total Revenue
193.0000
141.0000
135.0000
163.0000
Cost of Revenue
30.0000
--
850.0000
806.0000
Gross Profit
163.0000
141.0000
-715.0000
-643.0000
Operating Expense
23,631.0000
20,064.0000
16,344.0000
14,374.0000
Operating Income
-23,468.0000
-19,923.0000
-17,059.0000
-15,017.0000
Net Non Operating Interest Income Expense
1,144.0000
629.0000
-67.0000
-672.0000
Other Income Expense
1,549.0000
-151.0000
-2,001.0000
1,289.0000
Pretax Income
-20,775.0000
-19,445.0000
-19,127.0000
-14,400.0000
Net Income Common Stockholders
-20,775.0000
-19,445.0000
-19,127.0000
-14,400.0000
Diluted NI Available to Com Stockholders
-20,775.0000
-19,445.0000
-19,127.0000
-14,400.0000
Basic EPS
-0.43
-0.40
-0.40
-0.45
Diluted EPS
-0.43
-0.40
-0.40
-0.45
Basic Average Shares
48,382.7200
48,047.2880
47,339.9750
31,842.7990
Diluted Average Shares
48,382.7200
48,047.2880
47,339.9750
31,842.7990
Total Operating Income as Reported
-23,468.0000
-19,923.0000
-18,838.0000
-15,152.0000
Total Expenses
23,661.0000
20,064.0000
17,194.0000
15,180.0000
Net Income from Continuing & Discontinued Operation
-20,775.0000
-19,445.0000
-19,127.0000
-14,400.0000
Normalized Income
-20,683.0000
-17,804.0000
-14,807.0000
-14,503.0000
Interest Income
1,144.0000
629.0000
--
219.0000
Interest Expense
--
--
67.0000
672.0000
Net Interest Income
1,144.0000
629.0000
-67.0000
-672.0000
EBIT
-22,990.0000
-19,445.0000
-19,060.0000
-13,728.0000
EBITDA
-22,640.0000
-19,189.0000
-18,285.0000
-12,995.0000
Reconciled Cost of Revenue
30.0000
--
850.0000
806.0000
Reconciled Depreciation
350.0000
256.0000
775.0000
733.0000
Net Income from Continuing Operation Net Minority Interest
-20,775.0000
-19,445.0000
-19,127.0000
-14,400.0000
Total Unusual Items Excluding Goodwill
-92.0000
-1,641.0000
-4,320.0000
103.0000
Total Unusual Items
-92.0000
-1,641.0000
-4,320.0000
103.0000
Normalized EBITDA
-22,548.0000
-17,548.0000
-13,965.0000
-13,098.0000
12/31/2020 - 7/12/1996
Yahoo Finance Plus Essential access required. Unlock Access

Related Tickers